Drug Type Small molecule drug |
Synonyms ERX 208, ERX-208 |
Target |
Action inhibitors |
Mechanism LIPA inhibitors(lipase A, lysosomal acid type inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Ovarian Cancer | Preclinical | United States | 17 Jun 2022 |